F. Vanaclocha

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Novartis (Switzerland)17.3%
• Charité - Universitätsmedizin Berlin7.6%
• University of Manchester6.6%
• Icahn School of Medicine at Mount Sinai6.5%
• Oregon Health & Science University6.3%
• Eli Lilly (United States)6.1%
• Other49.6%

Fields

• Immunology and Microbiology61.4%
• Medicine30.5%
• Biochemistry, Genetics and Molecular Biology3.7%
• Health Professions2.1%
• Pharmacology, Toxicology and Pharmaceutics1.6%
• Agricultural and Biological Sciences0.2%
• Other0.5%

Topics

• Psoriasis: Treatment and Pathogenesis32.6%
• Dermatology and Skin Diseases22.4%
• Spondyloarthritis Studies and Treatments16%
• Rheumatoid Arthritis Research and Therapies4.6%
• Asthma and respiratory diseases4.3%
• Autoimmune and Inflammatory Disorders Research3.2%
• Other17%